Multiple myeloma care is rapidly evolving with new agents and combinations, new testing, and risk-adapted treatment strategies. Four highly experienced nurses will share their expertise during this 1.5 CNE symposium (3 sessions of 0.5 CNE) while using real-life patient case scenarios to focus on symptom management, infection control, and nursing implications. The participants can take part in a single session, two sessions, or the entire symposium. Free downloadable tools and resources are provided.
Available now, earn your CNE credits for these 3 activities!
Co-Chairs: Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; Joseph D. Tariman, PhD, RN, ANP-BC, FAAN
Faculty: Amy E. Pierre, RN, MSN, ANP-BC; Tiffany Richards, PhD, ANP-BC, AOCNP®
|
Part 1: Newly Diagnosed Multiple Myeloma Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; This activity on newly diagnosed multiple myeloma will include an overview of the disease, as well as current treatment workup and testing recommendations for multiple myeloma. Through the cases of June and Lisa, our faculty will explore transplant eligibility, induction, and maintenance therapy. Please remember to complete part 2 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.
|
 |
|
Part 2: Relapsed Multiple Myeloma
|
 |
|
Part 3: Heavily Pretreated Multiple Myeloma and Drugs in Development
|
 |
Provided by the International Myeloma Foundation
Accredited by Annenberg Center for Health Sciences at Eisenhower
Supported by educational grants from Bristol Myers Squibb (formerly Celgene); GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics Inc.; Oncopeptides, Inc.; and Takeda Oncology.